Clinical Trial Update: Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection [Phase 3]

View source ↗

Summary

A Phase 3 safety study evaluated the combination of Isentress (raltegravir) with Truvada (emtricitabine/tenofovir disoproxil fumarate) for post-exposure treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux | Conditions: HIV Infections | Phase 3 | Status: COMPLETED